Platelet-rich plasma injection may be effective for alopecia

December 7, 2017

(HealthDay)—Subcutaneous injection of platelet-rich plasma (PRP) may be effective for treating alopecia, according to an experimental study published Nov. 11 in the Journal of Cosmetic Dermatology.

Sophie Orliac, M.D., from Université Paris Diderot, and colleagues assessed the potential of PRP subcutaneous injection to treat alopecia and to evaluate local toxicity in 12 hairless rats. Subcutaneous occurred in four quadrants using either PRP, platelet-poor plasma (PPP), physiological serum (PS), or no treatment.

The researchers found that hair density was significantly improved at day 28 and at month six for PRP versus PS (P = 0.0156 and 0.0313, respectively) and PPP (P = 0.042 and 0.046, respectively). There was significant histological improvement between day 28 and month six for PRP versus PPP and PS for vessels (P = 0.0160 and 0.021, respectively), collagen (P = 0.0036 and 0.032, respectively), and epithelium (P = 0.0138 and 0.022, respectively). There was no local toxicity.

"Our study suggests that subcutaneous PRP injections using controlled concentration of platelets and leukocytes improve hair growth," the authors write.

Explore further: Platelet-rich plasma effective for female pattern hair loss

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Platelet-rich plasma effective for female pattern hair loss

May 18, 2017
(HealthDay)—For women with female pattern hair loss, autologous platelet-rich plasma (PRP) injections are effective and safe, according to a study published online May 14 in the Journal of Cosmetic Dermatology.

H2 injection aids diabetes outcomes in animal model

May 3, 2017
(HealthDay)—Subcutaneous injection of H2 significantly improves type 2 diabetes mellitus (T2DM)-related outcomes in a mouse model, according to a study published online April 8 in the Journal of Diabetes Investigation.

Platelet-rich plasma plus hyaluronic acid improves skin rejuvenation

August 24, 2017
(HealthDay)—Autologous platelet-rich plasma (PRP) combined with hyaluronic acid (HA) improves skin firmness and elasticity, according to a research letter published in the September issue of the Journal of the American ...

Platelet-rich plasma injection reduces facial wrinkles

August 8, 2016
(HealthDay)—Platelet-rich plasma (PRP) intradermal injection can reduce wrinkles, especially wrinkles of the nasolabial folds (NLFs), according to a study published online July 29 in the Journal of Cosmetic Dermatology.

CO2 laser + platelet-rich plasma promising treatment for vitiligo

August 28, 2017
(HealthDay)—Combination of fractional carbon dioxide (CO2) laser with platelet-rich plasma (PRP) injection is a promising treatment for vitiligo, according to a study published online Aug. 20 in the Journal of Cosmetic ...

Platelet-rich plasma effective for chronic venous leg ulcers

August 29, 2017
(HealthDay)—For patients with chronic venous leg ulcers, autologous platelet-rich plasma (PRP) is safe and effective, with highly significant improvement in ulcer size compared to conventional treatment, according to a ...

Recommended for you

Many doctors in India miss TB signs: study

September 25, 2018
Many private sector doctors in India miss the signs of tuberculosis and therefore provide patients inadequate treatment, according to a new study published Tuesday involving people hired to act out the symptoms.

Researchers seek vaccine for 'traveler's diarrhea'

September 25, 2018
Every year, millions of people have vacations and business trips ruined when they succumb to "traveler's diarrhea" during their journeys. A major cause of traveler's diarrhea is bacteria called Enterotoxigenic E. coli, or ...

New way of determining treatment for staph infections cuts antibiotic use

September 25, 2018
Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers ...

Breakthrough in designing a better Salmonella vaccine

September 24, 2018
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing ...

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

New findings on the muscle disease Laing early-onset distal myopathy

September 24, 2018
New avenues are now being opened toward treatment of Laing distal myopathy, a rare disorder that causes atrophy of the muscles in the feet, hands and elsewhere. In a study published in the journal PNAS, researchers have identified ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.